Analysis of odds ratio of increased relative risk of developing breast cancer in different groups of women

Taking into account the large number and variety of factors of breast cancer there is constant need and necessity to monitor the risk of developing the disease. It is important to take preventive actions - health education concerning lifestyle and possible ways to modify unhealthy aspects. Quantitive assessment of risk of developing invasive breast carcinoma can be performed using the Gail model (GM). This method is designed to estimate relative and cumulative risk during the entire lifetime or at a certain age of a patient, considering risk factors. It is possible to identify women with increased risk of breast carcinoma and to choose a proper diagnostic path. The purpose of this study was to estimate the relative risk (RR) and to analyze the odds ratio (OR) of increased risk of developing breast cancer. The participants in the study were healthy women with no focal changes in mammary glands and women with diagnosed malignant or benign breast neoplasms. The total number of participants was 555 females aged 35-70 years. The study was carried on in the Great Poland and Lubuskie provinces between 2005 and 2006. High 5-year relative risk of developing breast cancer assessed by the Gail method, proved that this method was a useful tool in confronting reality. In classification of women to a group of increased risk of breast carcinoma, apart from assessment by the Gail method, factors like: BMI, education, medical interventions in puerperium and number of cases of familial invasive cancers should be taken into account.

Breast cancer; Risk factors.

[1] Colditz G., Atwood K., Emmons K., Inni I.: “Harvard report on cancer prevention”. Cancer Causes Control, 2000, 11, 477.

[2] Norum J.: “Breast cancer screening by mammography in Nowary. Is it cost-effective?”. Ann. Onkol., 1999, 10, 197.

[3] Colditz G., De Jong W., Hunter D., Trichopoulos D., Willett W.C (eds.): “Harvard report on cancer prevention”. Cancer Causes Control, 1996, 7 (suppl.), S1.

[4] Euhus D.: “Understanding mathematical models for breast cancer risk assessment and counseling”. Breast J., 2001, 7, 4, 224.

[5] Stasiołek D., Kwa niewska M., Drygas W.: “Rak sutka-wybrane czynniki ryzyka, prewencja pierwotna”. Przeg. Lek., 2002, 59, 26.

[6] Bruning P.F.: “Body measurements, estrogen availability and the risk of human breast cancer: a case-control study”. Int. J. Cancer, 1992, 51, 14.

[7] London S.: “Prospective study of relative weight, height, and risk of breast cancer”. JAMA, 1989, 262, 2853.

[8] Tretli S.: “Height and weight In relation to breast cancer morbidity and mortality: a prospective study of 570,000 women in Nowary”. Inst. J. Cancer, 1989, 44, 23.

[9] Ballad-Barbash R.: “Anthropometry and breast cancer: body size a moving target”. Cancer, 1994, 74, 1090.

[10] Ballad-Barbash R., Swanson Ch.A.: “Body weight estimation of risk for breast cancer and endometrial cancer”. Am. J. Clin. Nutr., 1996, 63, 4375.

[11] La Vecchia C.: “Overweight and hormone related cancers”. E C P News, 1997, 30, 2.

[12] Mazurkiewicz M.: “Profilaktyka i metody wczesnego rozpoznania raka gruczołu piersiowego”. Med. Rodz., 2000, 10, 29.

[13] Budner M., Przybylski M.: “Diagnostyka i wczesne wykrywanie raka piersi. W. Post py w ginekologii i poło nictwie”. Red. Spaczy ski M., XXIX Kongres Polskiego Towarzystwa Gineko-logicznego, Pozna 2006, 87.

[14] Dworniak T.: “Rak sutka-profilaktyka”. Nowa Klinika, 2003, 10, 535.

[15] Godlewski D.: “Rak piersi w aspekcie medycznym i społecznym”. Pozna , 1997, 6.

[16] Tavani A., Gallus S., La-Vecchia C., Inni I.: “Risk factors for breast cancer in woman under 40 years”. Eur. J. Cancer, 1999, 35, 1361.

[17] Becher H., Schmidt S., Chang-Claude J.: “Reproductive factors and familial predisposition for breast cancer by age 50 years. A case-control-family study for assessing main effects and possible gene-environment interaction”. Int. J. Epidemiol., 2003, 32, 38.

[18] Jernstrom H., Lubi ski J., Lynch H.T. et al.: “Breast-feeding and the risc of breast cancer in BRCA1 and BRCA2 mutation carriers”. J. Natl. Cancer Inst., 2004, 96, 1094.

[19] Graja T., Grodecka-Gazdecka S.: “Czynniki wpływaj ce na jako ycia kobiet leczonych z powodu raka piersi”. Przeg. Położ. Ginek., 2005, 5, 115.

[20] Stojgniew J. Sitko, Hetnał M.: “Determinanty systemowe profilaktyki i leczenia raka sutka w Polsce”. Pielę. Pol., 2001, 1, 68.

[21] Budner M., Przybylski M.: “Diagnostyka i wczesne wykrywanie raka piersi. W: Post py w ginekologii i poło nictwie”. Red. Spaczy ski M, XXIX Kongres Polskiego Towarzystwa Ginekolog-icznego, Pozna 2006, 87.

[22] Ostrowska L., Czapska D., Karczewski J.: “Otyło jako czynnik ryzyka nowotworu sutka u kobiet”. Polski Merkuriusz Lekarski, 2003, 81, 224.